Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.650 | 3.650 | 0.000 |
Shares | 96.350 | 96.350 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.839 | 20.566 |
Price to Book | 2.473 | 4.169 |
Price to Sales | 1.122 | 2.466 |
Price to Cash Flow | 10.725 | 17.017 |
Dividend Yield | 2.692 | 1.350 |
5 Years Earnings Growth | 9.782 | 13.676 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.490 | 94.945 |
Basic Materials | 0.510 | 1.641 |
Number of long holdings: 45
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
GSK plc | GB00BN7SWP63 | 6.45 | 1,336.00 | +1.21% | |
Gilead | US3755581036 | 6.33 | 92.57 | +1.62% | |
Pfizer | US7170811035 | 5.50 | 26.36 | +2.29% | |
Roche Holding Participation | CH0012032048 | 5.00 | 250.60 | +1.29% | |
Bristol-Myers Squibb | US1101221083 | 4.88 | 57.33 | +1.83% | |
Medtronic | IE00BTN1Y115 | 4.58 | 81.03 | +1.30% | |
Sanofi | FR0000120578 | 3.81 | 92.12 | +0.92% | |
Novartis | CH0012005267 | 3.17 | 87.64 | +1.06% | |
UCB | BE0003739530 | 3.03 | 191.10 | +2.41% | |
Elevance Health | US0367521038 | 2.89 | 365.96 | -0.14% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BD4TRB36 | 435.2M | 5.22 | 3.21 | 8.92 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review